Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience

BACKGROUND: Recent evidence has raised concerns regarding the safety of the everolimus-eluting bioresorbable vascular scaffold (E-BVS) (Absorb, Abbott Vascular, Santa Clara, CA, USA). Following these data, the use of this device has diminished in the Netherlands; however, daily practice data are lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Remkes, W. S., Hermanides, R. S., Kennedy, M. W., Fabris, E., Kaplan, E., Ottervanger, J. P., van ’t Hof, A. W. J., Kedhi, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2017
Materias:
Original Article - E‑Learning
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653537/
https://www.ncbi.nlm.nih.gov/pubmed/28913627
http://dx.doi.org/10.1007/s12471-017-1038-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653537/
https://www.ncbi.nlm.nih.gov/pubmed/28913627
http://dx.doi.org/10.1007/s12471-017-1038-4

Ejemplares similares